Literature DB >> 7929538

Magnetic resonance imaging (MRI) in evaluation of left atrial masses: an in vitro and in vivo study.

D B Reddy1, A Jena, P Venugopal.   

Abstract

Thirty patients, 15 each of suspected of left atrial myxoma and clot were studied in a prospective study to assess the role of magnetic resonance imaging (MRI) in evaluation of left atrial masses. Upon clinical and echocardiographic suspicion of a left atrial mass, patients were subjected to ECG-gated MRI (in vivo study) and subsequently all of them underwent surgery for the removal of mass and/or mitral valve replacement/repair. Within 6 hours of its removal the mass was subjected to in vitro MRI study and subsequently to histopathological examination. During the study T1, T2 gated images were obtained and tissue characterization was done. A magnetic dye Gd-DTPA was used for contrast enhancement. Cine-display of the images was obtained to demonstrate dynamic movement of the mass across the mitral valve. MRI was found to be highly useful in delineating the exact anatomical details of left atrial masses. Results of MRI diagnosis with illustrations are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929538

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Atrial myxoma as a cause of stroke: case report and discussion.

Authors:  Fintan O'Rourke; Naeem Dean; Mikael S Mouradian; Naveed Akhtar; Ashfaq Shuaib
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

2.  A case of large atrial myxoma presenting as an acute stroke.

Authors:  Praneet Iyer; Myo Myo Aung; Muhammad Umer Awan; Charles Kososky; Kulpreet Barn
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-02-17

3.  Giant left atrial myxoma - literature review and case presentation.

Authors:  Victor Cornel Raicea; Horaţiu Suciu; Andrei Dan Raicea; Gheorghe Cosmin Macarie; Tibor Mezei; Maria Smaranda Maier
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.